Myomectomy for Fibroids during Cesarean Section: A Randomized Controlled Trial | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 3, Volume 86, Issue 1, January 2022, Pages 9-16 PDF (769.88 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2021.209970 | ||
| Authors | ||
| Ayman A. Shabana; Tarek M. Sayyed; Mohamed A. Rezk; Sara M. Nassar; Ayman Soliman* | ||
| Obstetrics and gynecology department, Faculty of Medicine, Menoufia University, Menoufia, Egypt | ||
| Abstract | ||
| Background: There is a considerable debate about the management of myoma during cesarean section (CS). Recently, several studies indicated the safety and feasibility of undertaking myomectomy during CS. Objectives: To evaluate the safety, accessibility, and short-term morbidity of myomectomy for fibroids during cesarean section. Patients and Methods: This was a randomized controlled trial that included 72 patients who were admitted to the Obstetrics & Gynecology Department, Menoufia University Hospital with uterine fibroids during pregnancy; who were randomly allocated equally into a group of cesarean myomectomy (CM; n=36) and another group of CS only (n=36). The operative events and the outcome were recorded and analyzed. Results: CM group showed a longer duration of surgery and longer hospital stay, higher amount of blood loss, and higher mean pain sores, with a highly statistically significant difference (p = 0.000). No cases in both groups required blood transfusion or ICU admission. No statistically significant differences were noted between both groups as regards the fetal outcome measures (p=0.583 & 0.601). Conclusion: CM is safe and applicable in selected cases without deleterious maternal complications. Special precautions ought to be paid during the procedure, particularly in the intramural type and with large fibroids. | ||
| Keywords | ||
| Cesarean myomectomy; Fetal outcome; Maternal outcome; Safety; Uterine fibroid | ||
|
Statistics Article View: 342 PDF Download: 501 |
||
